Clinipace

Clinipace, Medfiles partner

Monday, August 5, 2013 11:55 AM

Global CRO Clinipace Worldwide has partnered with Finland-based CRO Medfiles, which specializes in pharmaceutical development and analytical services, clinical trial support, health economics and regulatory affairs.

More... »

Clinipace Worldwide acquires Paragon Biomedical

Tuesday, September 25, 2012 07:00 AM

Clinipace Worldwide, a global digital contract research organization (dCRO), and Paragon Biomedical, a global, full-service CRO, have jointly announced a definitive merger agreement under which Morrisville, N.C.-based Clinipace Worldwide has acquired all outstanding shares of privately-held, Irvine, Calif.-based Paragon and its subsidiaries.

More... »

Clinipace Worldwide to manage Prometheus oncology program

Wednesday, July 18, 2012 01:29 PM

Morrisville, N.C.-based Clinipace Worldwide, a global digital research organization (dCRO), said Prometheus Laboratories, a specialty pharmaceutical and diagnostic company, has awarded it an Oncology Program.  Immediate plans are commencing for two metastatic melanoma studies.  

More... »

Clinipace names VP, European clinical operations

Wednesday, November 2, 2011 12:17 PM

Clinipace Worldwide has named Andrea Schiefer, Ph.D., vice president of European clinical operations and executive director of pharmacovigilance. In this position, Andrea reports directly to Kurt Pfister, chief executive officer of European operations at Clinipace Worldwide, and is responsible for providing leadership and direction to the project management, clinical monitoring and safety groups within the European clinical operations unit at Clinipace Worldwide.

More... »

Larus joins Clinipace Worldwide

Tuesday, October 18, 2011 02:04 PM

Clinipace Worldwide has named John Larus executive vice president of clinical operations. In this newly created position, John reports directly to Chris Porter, chief operating officer, and is responsible for providing leadership and direction to the project management, clinical monitoring and safety groups within the U.S. clinical operations unit.

More... »

Clinipace secures $15M in Series C financing

Tuesday, September 27, 2011 12:34 PM

Clinipace Worldwide has closed a $15M Series C round of funding led by Morgan Stanley Expansion Capital of San Francisco, CA.  Existing investors, including Hatteras Venture Partners of Durham, NC, and Brook Private Equity Advisors of Boston, MA, also participated in this most recent round of funding.

More... »

Clinipace acquires PFC Pharma Focus

Monday, May 23, 2011 08:47 AM

While industry news has been dominated by medium to large CRO acquisitions, consolidation is taking place in the smaller end of the market, too. Last Wednesday morning, CRO Clinipace Worldwide announced it has acquired Swiss CRO PFC Pharma Focus.

More... »

CRO Clinipace Worldwide acquires PFC Pharma Focus

Wednesday, May 18, 2011 05:01 AM

Recent industry news has been dominated by stories of medium to large CROs acquiring one another or being acquired by investment companies. But consolidation is taking place in the smaller end of the market, too. This morning, CRO Clinipace Worldwide announced it has acquired Swiss CRO PFC Pharma Focus.

More... »

Plexxikon selects Clinipace to manage trials

Friday, March 18, 2011 10:51 AM

Plexxikon, a company focused on the discovery and development of novel small molecule pharmaceuticals to treat human disease, has selected Clinipace Worldwide, a digital CRO, to manage all aspects of four clinical trials comprising a phase I healthy volunteer study, a phase Ib rheumatoid arthritis (RA) study and two phase II oncology studies. 
  
“We chose Clinipace Worldwide to manage these important clinical trials based on Clinipace’s commitment to customer service,” said Paul Lin, MD, MBA, director of business development at Plexxikon. “Plexxikon’s programs are highly differentiated from its competition, and we needed a highly differentiated CRO to get the job done.”

More... »

Clinipace Worldwide acquires Regulus Pharmaceutical Consulting

Tuesday, March 1, 2011 11:56 AM

Clinipace Worldwide, a global digital CRO based in Morrisville, N.C., has acquired Regulus Pharmaceutical Consulting, a regulatory affairs and quality assurance consultancy based in Boulder, Colo.  

More... »